The Valley Desk

NCT04660929 · Interventional trial

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Overall registry status Unknown

Phase 1

Conditions Adenocarcinoma, Bile Duct Cancer, Biliary Tract Cancer, Bladder Cancer, Breast Cancer, Breast Neoplasm, Cancer, Carcinoma, Ductal, Carcinoma, Hepatocellular, Carcinoma, Ovarian Epithelial, Carcinoma, Small Cell, Carcinoma, Squamous, Carcinoma, Transitional Cell, Colorectal Cancer, Endometrial Cancer, Esophagogastric Junction Neoplasms, HER-2 Gene Amplification, HER-2 Protein Overexpression, HER2-positive, HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Solid Tumors, Head and Neck Cancer, Inflammatory Breast Cancer, Lung Cancer, Non-Small-Cell, Lung Cancer, Small Cell, Malignant Neoplasms, Ovarian Neoplasms, Pancreatic Cancer, Prostate Cancer, Stomach Neoplasms

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov